LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,360,000 | -8.8% | 8,921 | -40.5% | 0.01% | 0.0% |
| Q4 2020 | $1,492,000 | +5.7% | 15,004 | +1.4% | 0.01% | 0.0% |
| Q3 2020 | $1,411,000 | -4.5% | 14,804 | +12.1% | 0.01% | -16.7% |
| Q2 2020 | $1,477,000 | +30.1% | 13,204 | -15.4% | 0.01% | +20.0% |
| Q1 2020 | $1,135,000 | -20.0% | 15,604 | +14.7% | 0.01% | 0.0% |
| Q4 2019 | $1,419,000 | -8.0% | 13,604 | -12.3% | 0.01% | +11.1% |
| Q3 2019 | $1,543,000 | -16.1% | 15,504 | -3.7% | 0.01% | -30.8% |
| Q2 2019 | $1,838,000 | +120.9% | 16,104 | +143.2% | 0.01% | +116.7% |
| Q1 2019 | $832,000 | -10.2% | 6,621 | -2.9% | 0.01% | -25.0% |
| Q4 2018 | $926,000 | -52.6% | 6,821 | -4.1% | 0.01% | -46.7% |
| Q3 2018 | $1,952,000 | +30.6% | 7,113 | -1.4% | 0.02% | +50.0% |
| Q2 2018 | $1,495,000 | -2.8% | 7,213 | -22.5% | 0.01% | 0.0% |
| Q1 2018 | $1,538,000 | – | 9,313 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |